Cargando…

Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review

BACKGROUND: Standard treatment for differentiated thyroid cancer is thyroidectomy followed in selected cases by radioiodine ablation (ra). Recombinant humanized thyroid-stimulating hormone (rhtsh) is an exogenous source of tsh that can be administered to obviate the need for hormone withdrawal. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, J., Cosby, R., Driedger, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2009
Materias:	Practice Guidelines Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768506/ https://www.ncbi.nlm.nih.gov/pubmed/19862359

Ejemplares similares

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
por: Sohn, Seo Young, et al.
Publicado: (2015)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020)

Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status
por: Van Uytfanghe, Katleen, et al.
Publicado: (2023)

The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Pak, Kyoungjune, et al.
Publicado: (2014)

Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study
por: Mäenpää, Hanna O., et al.
Publicado: (2008)

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
por: Pillarisetti, Jayasree, et al.
Publicado: (2020)

Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine‐treated cats
por: Wakeling, Jennifer, et al.
Publicado: (2020)

A framework for the organization and delivery of systemic treatment
por: Vandenberg, T., et al.
Publicado: (2009)

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement
por: Ellis, P.M., et al.
Publicado: (2009)

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
por: Melosky, B., et al.
Publicado: (2009)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer
Publicado: (2009)

Clinician–patient communication: evidence-based recommendations to guide practice in cancer
por: Rodin, G., et al.
Publicado: (2009)

Canadian supportive care recommendations for the management of neutropenia in patients with cancer
por: Kouroukis, C.T., et al.
Publicado: (2008)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Treatment of depression in cancer patients
por: Rodin, G., et al.
Publicado: (2007)

Canadian supportive care recommendations for the management of anemia in patients with cancer
por: Mikhael, J., et al.
Publicado: (2007)

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group
por: Maroun, J., et al.
Publicado: (2006)

Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007)

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

Alemtuzumab in chronic lymphocytic leukemia
por: Fraser, G., et al.
Publicado: (2007)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer
por: Hanna, W., et al.
Publicado: (2007)

Management of single brain metastasis: a practice guideline
por: Mintz, A., et al.
Publicado: (2007)

Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline
por: Reece, D., et al.
Publicado: (2006)

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer
por: Jonker, D., et al.
Publicado: (2006)

The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review
por: Perry, J., et al.
Publicado: (2006)

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
por: Lv, Rong-Bin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bmifjg0l30c05dgbal46bekn6q